• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Axogen













































Recruiter is quoting me 100k for the territory in its current shape but most reps are making 160K-180K. Can anyone give me some insight?
\

Of course the recruiter is saying 160-180k. Might the recruiter be MC? Fact, most reps there are NOT making 160-180K. $110-130 is the norm. Nice little company with a one of a kind product. Good place for a someone looking to begin a career in device. Comp is targeted towards entry level to 1-2 yrs prior device sales.
 




Who is Shawn? Can anyone give their thoughts as to the products, company culture, compensation, etc.?

I worked @ AxoGen but, left before Shawn arrived. Heard is a good guy. Karen the CEO is good people as were most of the drivers of the company. I left AxoGen only because I found an opportunity that offered better compensation.

Pros - good work environment ; no big company CYA, check the box type of nonsense; easy product to learn; good product in Avance

Cons- specialty products for specialty cases for small set of surgeons which means you need lots of volume and lots of surgeons to drive sales; compensation is below medical sales average; no hospital contracts; longevity of company is a question; high turnover

Good place to begin a career in medical sales or to use as bridge while looking for something better. Not a good match for experienced reps or reps looking for big pay days. The average rep was not @ $160-180. LOL:)
 








I think I am going to be sick - How many VP of Sales have there been (3)

How many reps have they burned through? Too many to count

Does anyone in management have start up experience?

Why are management $$ so high? The protected few reward themselves north of $300k

How long has this been on the market?

What happened to the Stryker deal?

More debt every year, More $$ for management every year

Reps are lower than bathroom attendants at this company.
 








I think I am going to be sick - How many VP of Sales have there been (3)

How many reps have they burned through? Too many to count

Does anyone in management have start up experience?

Why are management $$ so high? The protected few reward themselves north of $300k

How long has this been on the market?

What happened to the Stryker deal?

More debt every year, More $$ for management every year

Reps are lower than bathroom attendants at this company.


What the brain child's running this company never realized is if you comp your reps with a decent base and attainable realistic quotas you might attract and keep qualified personnel who could drive sales. About a handful of reps ever smell quota attainment. Fleabag organization with selfish clueless management. Explains why they have done nutten in 7 years.
 




Do not work for this company! Corporate Officers have no idea about the actual/realistic number of nerve repairs that take place. They underestimate the number of direct suture repairs and therefore create unrealistic quotas. They hire VP's of Sales from large companies who have no idea how a smaller, niche, biologic product should be sold. Rep turnover is high because you cannot achieve your quota and they are cutting territories in half by adding sub-reps. The real unfortunate thing is that the product is actually quite awesome and is superior to other nerve repair alternatives although it is much more expensive. That obstacle can be overcome rather easily. The OR procedures are interesting and you can create good relationships with the surgeons. But let me repeat myself-you cannot trust the leaders who run this company.
 




Do not work for this company! Corporate Officers have no idea about the actual/realistic number of nerve repairs that take place. They underestimate the number of direct suture repairs and therefore create unrealistic quotas. They hire VP's of Sales from large companies who have no idea how a smaller, niche, biologic product should be sold. Rep turnover is high because you cannot achieve your quota and they are cutting territories in half by adding sub-reps. The real unfortunate thing is that the product is actually quite awesome and is superior to other nerve repair alternatives although it is much more expensive. That obstacle can be overcome rather easily. The OR procedures are interesting and you can create good relationships with the surgeons. But let me repeat myself-you cannot trust the leaders who run this company.


I too do not work for AxoGen but, I know the leaders of this company are not trusted by the reps and yes, they have absolutely no ¥¥¥¥¥ clue of real nerve market. I know for a fact they bring reps in under false hopes of compensation and growth potential within a territory and then act surprised when the 50-60% quotas are not obtained. JS, KZ, SM and their yes managers are small company hacks who may know this product but, lack professionalism, integrity and honesty. Turnover is very high and I know morale is not good for those who are there. This small company will continue its chronic struggle until the small minded cheap ¥¥¥¥¥ driving the bus begin to realize they have a broken business model that isn't working.
 




I too do not work for AxoGen but, I know the leaders of this company are not trusted by the reps and yes, they have absolutely no ¥¥¥¥¥ clue of real nerve market. I know for a fact they bring reps in under false hopes of compensation and growth potential within a territory and then act surprised when the 50-60% quotas are not obtained. JS, KZ, SM and their yes managers are small company hacks who may know this product but, lack professionalism, integrity and honesty. Turnover is very high and I know morale is not good for those who are there. This small company will continue its chronic struggle until the small minded cheap ¥¥¥¥¥ driving the bus begin to realize they have a broken business model that isn't working.

I did work for here for a period of time and the posts written here are fairly accurate. Avance is a really good product and can make a difference in patients lives. Main selling obstacles are iit's a niche product, it adds cost, and it requires a good deal of time to convert the end user and get approvals. Biggest issue of all is managements admitted lack of knowledge of the nerve repair arena. This lack of understanding is passed along in unrealistic quotas, amateur comp plans and poor payouts. Which in turn explains the high turnover amongst reps and managers. Sad, good product.